Poseida Therapeutics, Inc.

Q3 2023 13F Holders

Symbol
PSTX
CUSIP
73730P108
Type
Equity
Class
COM
Num filings
91
Total reported value, excl. options
$108 M
Manager Report Date Value ($000) Shares Option Type